Loading
institutionsInstitution
Hamad Medical Corporation / National Center for Cancer Care and Research
Qatar's public health system, whose National Center for Cancer Care and Research is the country's sole comprehensive cancer centre and the hub of its national cancer strategy.
Also called: HMCNCCCRAl Amal Hospitalمؤسسة حمد الطبية
Overview
Hamad Medical Corporation, established in 1979, runs Qatar's public hospitals, and its National Center for Cancer Care and Research (formerly Al Amal Hospital) is the national cancer centre delivering medical, surgical and radiation oncology, haematology and bone marrow transplant, palliative care and a growing clinical trials programme. Qatar's National Cancer Strategy and National Cancer Program, with Sidra Medicine for paediatrics and the Qatar Biobank and Qatar Genome Programme for research, position HMC as a testbed for population genomics and early-detection initiatives in an Arab population, and NCCCR has been accredited by the Joint Commission and partners with academic centres in Europe and North America on training and trials.
Location
Doha, QA
Type
hospital
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#297 · 22 points (0 Newsweek + 0 NCI + 22 from 11 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Hamad Medical Corporation, including child institutions. 258 works · 4,012 citations · 77% open access · 9% clinical trials · 6% reviews.
Oncology works per year
472022
462023
482024
722025
452026
Most works
- Shahab Uddin M.S.23 works
- Abdulqadir J. J. Nashwan20 works
- Mahmood Al‐Dhaheri19 works
- Amjad C. Parvaiz18 works
- Said Dermime14 works
- Ali Toffaha12 works
- Khaled Murshed11 works
- Maysaloun Merhi11 works
- Shereen Elazzazy10 works
- Queenie Fernandes10 works
Most cited
- National Center for Cancer Care and Research
- National cancer strategy
- Bone marrow transplant
- Qatar Genome collaboration
Similar pages
- InstitutionKing Faisal Specialist Hospital and Research Centre
Shares Sultan Qaboos Comprehensive Cancer Care and Research Centre, Bahrain Oncology Center, King Hamad University Hospital, Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing.
- InstitutionRamathibodi Hospital, Mahidol University
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer.
- InstitutionTata Medical Center, Kolkata
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, Diffuse large B-cell lymphoma, IMRT / IGRT (modern external beam).
- InstitutionKing Hussein Cancer Center
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Diffuse large B-cell lymphoma, HR-positive / HER2-negative breast cancer.
- InstitutionRambam Health Care Campus
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
- InstitutionHospital Universitari i Politècnic La Fe
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer.
- PersonStephen J. Forman
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, Diffuse large B-cell lymphoma.
- InstitutionUniversity of Malaya Medical Centre
Shares Germline (hereditary) testing, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer, Colorectal cancer.